Company intelligence / Profile preview

Arbel Medical

Yokneam Illit, Israel

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Arbel Medical is an Israeli medical device company specializing in advanced cryoablation technology for the treatment of breast tumors. The company's flagship system uses liquid nitrogen to freeze and destroy benign breast fibroadenomas and is being investigated for the treatment of malignant breast cancer. By providing a minimally invasive, office-based alternative to surgical excision, Arbel Medical aims to improve patient outcomes and reduce healthcare costs. The technology is designed for ease of use, utilizing a thin needle-like probe guided by ultrasound to precisely target and ablate abnormal tissue.

Therapeutic areas: OncologyWomen's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Arbel Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arbel Medical.

Explore the full profile